Inhibikase Therapeutics, Inc. (IKT) › Total AssetsInhibikase Therapeutics, Inc. (IKT) — Total AssetsAnnual figures by period end, from SEC filings.2020-12-31: $14.78M2021-12-31: $42.47M2022-12-31: $24.94M2023-12-31: $14.51M2024-12-31: $98.60M2025-12-31: $181.20M$181.20M2020-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$181.20M+83.8%2026-03-26Balance as of period end2024-12-31$98.60M+579.7%2026-03-26Balance as of period end2023-12-31$14.51M-41.8%2025-03-27Balance as of period end2022-12-31$24.94M-41.3%2024-03-27Balance as of period end2021-12-31$42.47M+187.3%2023-03-31Balance as of period end2020-12-31$14.78M—2022-03-31Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)